|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 35.43 EUR | +0.25% |
|
+5.26% | +3.23% |
| Jan. 20 | Banco BPM says ECB, EBA both reviewing use of 'Danish Compromise' in Anima bid | RE |
| Jan. 17 | AXA : JP Morgan keeps its Buy rating | ZD |
| Capitalization | 75.12B 78.12B 70.92B 63.51B 112B 6,735B 125B 862B 319B 2,778B 293B 287B 12,161B | P/E ratio 2024 * |
10.1x | P/E ratio 2025 * | 8.68x |
|---|---|---|---|---|---|
| Enterprise value | 89.42B 92.99B 84.42B 75.6B 133B 8,017B 148B 1,026B 380B 3,307B 349B 342B 14,476B | EV / Sales 2024 * |
0.82x | EV / Sales 2025 * | 0.83x |
| Free-Float |
72.91% | Yield 2024 * |
6.12% | Yield 2025 * | 6.56% |
More valuation ratios
* Estimated data
More news
Last Transcript: AXA
| AXA : JP Morgan keeps its Buy rating | Jan. 17 | ZD |
| AXA : Receives a Buy rating from Jefferies | Jan. 15 | ZD |
| Autonomous Research Upgrades Axa to Outperform, Raises PT | Dec. 18 | MT |
| AXA : JP Morgan reaffirms its Buy rating | Dec. 04 | ZD |
| AXA : Berenberg keeps its Buy rating | Nov. 25 | ZD |
More press releases
More news
| 1 day | +0.23% | ||
| 1 week | +5.23% | ||
| Current month | +3.21% | ||
| 1 month | +5.29% | ||
| 3 months | -0.84% | ||
| 6 months | +9.97% | ||
| Current year | +3.21% |
1 week
33.87
35.54
1 month
33.1735.54
Current year
33.1735.54
1 year
29.0436.66
3 years
20.3436.66
5 years
11.8436.66
10 years
11.8436.66
| Director | Title | Age | Since |
|---|---|---|---|
Thomas Buberl
CEO | Chief Executive Officer | 51 | 2016-08-31 |
| Director of Finance/CFO | - | 2021-06-30 | |
| Chief Operating Officer | - | 2021-11-30 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 69 | 2009-04-29 | |
Thomas Buberl
BRD | Director/Board Member | 51 | 2016-08-31 |
| Director/Board Member | 67 | 2016-04-26 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.89% | 0 M€ | +4.56% | ||
| 1.80% | 130 M€ | +6.39% |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| +0.34% | +5.23% | +15.32% | +28.73% | 78.12B | ||
| +0.87% | +2.51% | +27.07% | -6.72% | 114B | ||
| +1.04% | +5.95% | +25.97% | +30.57% | 60.09B | ||
| +0.53% | +3.90% | +26.22% | +72.04% | 59.16B | ||
| -0.05% | +4.02% | +55.39% | +72.75% | 53.41B | ||
| +0.24% | +2.72% | +43.97% | +61.30% | 46.8B | ||
| +0.52% | +2.34% | +15.05% | +5.85% | 42.37B | ||
| +1.17% | +4.38% | +44.22% | +12.18% | 38.11B | ||
| -0.23% | +3.09% | +24.07% | +19.31% | 34.05B | ||
| -0.37% | -0.41% | +6.91% | +19.11% | 29.81B | ||
| Average | +0.38% | +3.69% | +28.42% | +31.51% | 55.55B | |
| Weighted average by Cap. | +0.47% | +3.77% | +28.35% | +29.29% |
| 2024 * | 2025 * | |
|---|---|---|
| Net sales | 109B 113B 103B 91.83B 162B 9,737B 180B 1,246B 462B 4,017B 424B 415B 17,582B | 107B 112B 101B 90.81B 160B 9,629B 178B 1,232B 457B 3,972B 419B 410B 17,387B |
| Net income | 7.78B 8.09B 7.35B 6.58B 11.59B 698B 12.92B 89.26B 33.08B 288B 30.35B 29.73B 1,260B | 8.75B 9.1B 8.26B 7.4B 13.02B 784B 14.53B 100B 37.18B 324B 34.12B 33.41B 1,416B |
| Net Debt | 14.3B 14.87B 13.5B 12.09B 21.29B 1,282B 23.75B 164B 60.78B 529B 55.78B 54.62B 2,315B | 14.3B 14.87B 13.5B 12.09B 21.29B 1,282B 23.75B 164B 60.78B 529B 55.78B 54.62B 2,315B |
More financial data
* Estimated data
Employees
94,705
Sector
Life & Health Insurance
Calendar
2025-02-27
- Q4 2024 Earnings Release
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-01-21 | 35.43 € | +0.25% | 163,652 |
| 25-01-20 | 35.34 € | -0.06% | 3,307,881 |
| 25-01-17 | 35.36 € | +0.80% | 4,440,865 |
| 25-01-16 | 35.08 € | +1.98% | 4,383,239 |
| 25-01-15 | 34.40 € | +2.20% | 5,182,708 |
Real-time Euronext Paris, January 21, 2025 at 03:10 am EST
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
35.34EUR
Average target price
40.19EUR
Spread / Average Target
+13.71%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- CS Stock
